Physician profile
Jill Humphrey
NPI 1790874402
$1,038.25
in general payments reported to CMS, 2019-2025
19 companies · $240 in 2025
The $240 reported for 2025 was more than what 79% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $16.92 · 2021: $134 · 2022: $159 · 2023: $260 · 2024: $81.48 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $149.15 | 2023-2024 | Qelbree, Qelbree |
| Cranial Technologies, INC | $129.46 | 2019-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $90.42 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $85.78 | 2021-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Kyowa Kirin, INC. | $82.62 | 2025 | |
| Sobi, INC | $82.35 | 2019-2022 | |
| Sanofi Pasteur INC. | $74.04 | 2022-2025 | |
| Pfizer INC. | $47.96 | 2019-2023 | |
| Shire North American Group INC | $41.14 | 2019 | |
| Baxter Healthcare | $38.97 | 2022 | |
| Welch Allyn | $38.97 | 2021 | |
| Glaxosmithkline, LLC. | $36.52 | 2025 | Bexsero, Penmenvy, Menveo |
| Takeda Pharmaceuticals U.S.A., INC. | $34.25 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $23.35 | 2023 | |
| Verrica Pharmaceuticals INC. | $22.27 | 2025 | Ycanth |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $17.54 | 2022 | |
| Neos Therapeutics, Lp | $16.92 | 2020 | |
| Genentech USA, INC. | $14.06 | 2019 | |
| Adlon Therapeutics L.P. | $12.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Humphrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.